On November 10, 2021, six new convergence environments at the University of Oslo (UiO) were announced. Such environments are dedicated to perform "beyond state-of-the-art" science, by recruiting and developing research talents, and promoting innovation within the life sciences.
One of the convergence environments was UiO:RealArt, led by PharmaTox professor Hedvig Nordeng. With a multidisciplinary team of researchers, UiO:RealArt will use machine learning on health data and simulated data to understand the causal relationship between medication use in pregnancy and child development.
![Image may contain: Slope, Font, Rectangle, Parallel, Circle.](/farmasi/english/research/groups/pharma-safe/news/2021/fig1_uiorealart.png)
In addition to Hedvig Nordeng, the principal investigators of UiO:RealArt are:
- Professor Janne von Torkildsen, Dpt. of Special Needs Education, Faculty of Educational Sciences, UiO
- Professor Eivind Ystrøm, Genetic research group, PROMENTA, Dpt. of Psychology, Faculty of Social Sciences, UiO
- Researcher Kristina Gervin, Div. Clinical Neuroscience, Oslo University Hospital and UiO
- Professor Geir Kjetil Sandve, Section for Machine Learning, Dpt. of Informatics, Faculty of Mathematics and Natural Sciences, UiO
- Dr. Chakravarthi Kanduri, Centre for Bioinformatics, Dpt. of Informatics, Faculty of Mathematics and Natural Sciences, UiO
![](/farmasi/english/research/groups/pharma-safe/news/2021/image.png)
We are very excited about this opportunity, and look forward to follow UiO:RealArt and their work in the years to come!
Read more about UiO:RealArt here.